Biologics for eosinophilic oesophagitis: a systematic review ...
Abstract Objective Advancing the understanding of the pathophysiology of eosinophilic oesophagitis (EoE) and other eosinophilic gastrointestinal diseases (EGIDs) has spurred …
Current state of biologics in treating eosinophilic esophagitis
Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if left untreated. This …
Biologics in the Treatment of Eosinophilic Esophagitis: Ready ...
Eosinophilic esophagitis (EoE) is a chronic disease mediated by environmental allergens and type 2 immune inflammation, which causes significant symptoms including dysphagia and food …
Biologics in eosinophilic esophagitis - PubMed
Biologics for treatment of EoE may result in symptom and histologic improvement and has the potential to treat disease with minimal side effects.
DUPIXENT® (dupilumab) For Eosinophilic Esophagitis
Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year and older who weigh at least 33lb …